GreenVision Acquisition, a blank check company led by Shanghai dealmakers targeting healthcare firms outside of China, raised $50 million by offering 5 million units at $10 to command a market value of $63 million. Each unit consists of one share of common stock, one warrant, and one right to receive one-tenth of a share of common stock.
GreenVision Acquisition plans to list on the Nasdaq under the symbol GRNVU. I-Bankers Securities acted as a lead manager on the deal.
